Related Experiment Video
Updated: Jun 24, 2026
11:15
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
Immune therapies for neuroblastoma
Fariba Navid1, Michael Armstrong, Raymond C Barfield
1Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN 38105 , USA. fariba.navid@stjude.org
Cancer Biology & Therapy
|April 4, 2009
Summary
Immunotherapy offers new hope for treating high-risk neuroblastoma, a common childhood cancer. Advances in cytokine, vaccine, antibody, and cellular therapies show promise for improving patient outcomes.
Area of Science:
- Pediatric Oncology
- Immunology
- Cancer Research
Background:
- Neuroblastoma is the most common pediatric extracranial solid tumor.
- High-risk neuroblastoma has a poor prognosis with current treatments.
- Novel therapeutic strategies are urgently needed.
Purpose of the Study:
- To review recent advancements in immunotherapy for neuroblastoma.
- To highlight promising preclinical and clinical trial findings.
- To discuss the potential of multimodal immunotherapy approaches.
Main Methods:
- Review of preclinical research and clinical trials.
- Focus on four main immunotherapy types: cytokine, vaccine, antibody, and cellular therapy.
- Examination of specific agents like IL-12, dendritic cell vaccines, anti-GD2 antibodies, and stem cell transplantation.
Main Results:
- Several immunotherapy candidates show significant promise.
- Interleukin-12 (IL-12), dendritic cell vaccines, anti-GD2 antibodies, and allogeneic hematopoietic stem cell transplant are notable examples.
- Preclinical data and early clinical trials support their efficacy.
Conclusions:
- Immunotherapy represents a promising alternative for neuroblastoma treatment.
- Combination therapies and multimodal approaches are likely key to optimal treatment plans.
- Further research and clinical trials are warranted to refine these strategies.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...